Search

Haswell, Jeffrey R, Kaia Mattioli, Chiara Gerhardinger, Philipp G Maass, Daniel J Foster, Paola Peinado, Xiaofeng Wang, Pedro P Medina, John L Rinn, and Frank J Slack. 2021. “Genome-Wide CRISPR Interference Screen Identifies Long Non-Coding RNA Loci Required for Differentiation and Pluripotency.”. PloS One 16 (11): e0252848.

Karimnia, Vida, Frank J Slack, and Jonathan P Celli. 2021. “Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma.”. Cancers 13 (17).

Ramírez-Moya, Julia, Christos Miliotis, Allison R Baker, Richard I Gregory, Frank J Slack, and Pilar Santisteban. 2021. “An ADAR1-Dependent RNA Editing Event in the Cyclin-Dependent Kinase CDK13 Promotes Thyroid Cancer Hallmarks.”. Molecular Cancer 20 (1): 115.

Orellana, Esteban A, Qi Liu, Eliza Yankova, Mehdi Pirouz, Etienne De Braekeleer, Wencai Zhang, Jihoon Lim, et al. 2021. “METTL1-Mediated M7G Modification of Arg-TCT TRNA Drives Oncogenic Transformation.”. Molecular Cell 81 (16): 3323-3338.e14.

Miliotis, Christos, and Frank J Slack. 2021. “MiR-105-5p Regulates PD-L1 Expression and Tumor Immunogenicity in Gastric Cancer.”. Cancer Letters 518: 115-26.

Li, Wen Jess, Yunfei Wang, Ruifang Liu, Andrea L Kasinski, Haifa Shen, Frank J Slack, and Dean G Tang. 2021. “MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic.”. Frontiers in Cell and Developmental Biology 9: 640587.

Malik, Shipra, Jihoon Lim, Frank J Slack, Demetrios T Braddock, and Raman Bahal. 2020. “Next Generation MiRNA Inhibition Using Short Anti-Seed PNAs Encapsulated in PLGA Nanoparticles.”. Journal of Controlled Release : Official Journal of the Controlled Release Society 327: 406-19.

Segal, Meirav, and Frank J Slack. 2020. “Challenges Identifying Efficacious MiRNA Therapeutics for Cancer.”. Expert Opinion on Drug Discovery 15 (9): 987-92.

Ramírez-Moya, Julia, Allison R Baker, Frank J Slack, and Pilar Santisteban. 2020. “ADAR1-Mediated RNA Editing Is a Novel Oncogenic Process in Thyroid Cancer and Regulates MiR-200 Activity.”. Oncogene 39 (18): 3738-53.

Niwa, Ryusuke, Kazumasa Hada, Kouichi Moliyama, Ryosuke L Ohniwa, Yi-Meng Tan, Katherine Olsson-Carter, Woo Chi, Valerie Reinke, and Frank J Slack. 2009. “C. Elegans Sym-1 Is a Downstream Target of the Hunchback-Like-1 Developmental Timing Transcription Factor.”. Cell Cycle (Georgetown, Tex.) 8 (24): 4147-54.